Clinical Trial Update: Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

View source ↗

Summary

An observational study evaluating Oralair grass pollen immunotherapy in children aged 5-9 with grass pollen–induced allergic rhinitis with or without conjunctiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Oralair (grass pollen sublingual immunotherapy tablet)

Snippet

Sponsor: Stallergenes Greer | Conditions: Allergy | Status: COMPLETED